Cargando…
Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
BACKGROUND: Chronic obstructive pulmonary disease is a major inflammatory disease of the airways and an enormous therapeutic challenge. Within the spectrum of chronic obstructive pulmonary disease, pulmonary emphysema is characterized by the destruction of the alveolar walls with an increase in the...
Autores principales: | Stessuk, Talita, Ruiz, Milton Artur, Greco, Oswaldo Tadeu, Bilaqui, Aldemir, Ribeiro-Paes, Maria José de Oliveira, Ribeiro-Paes, João Tadeu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e
Hemoterapia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832317/ https://www.ncbi.nlm.nih.gov/pubmed/24255620 http://dx.doi.org/10.5581/1516-8484.20130113 |
Ejemplares similares
-
Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
por: Ribeiro-Paes, João Tadeu, et al.
Publicado: (2011) -
Comment on “Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study”
por: Stessuk, Talita, et al.
Publicado: (2020) -
Autologous Infusion of Bone Marrow and Mesenchymal Stromal Cells in Patients with Chronic Obstructive Pulmonary Disease: Phase I Randomized Clinical Trial
por: Squassoni, Selma Denis, et al.
Publicado: (2021) -
Comment on: Phase I clinical trial of cell therapy in patients with
advanced chronic obstructive pulmonary disease: follow-up of up to 3
years
por: Bydlowski, Sergio Paulo
Publicado: (2013) -
A new experimental model of cigarette smoke-induced emphysema in Wistar
rats,
por: Kozma, Rodrigo de las Heras, et al.
Publicado: (2014)